ICRA Limited

RPG Life Sciences Limited

Sector : Pharmaceuticals & Biotechnology Sub Sectors : Pharmaceuticals

30 Apr 2025 RPG Life Sciences Limited: RPG Life Sciences Limited-CPR-30042025

Home Credit Perspective Reports RPG Life Sciences Limited

Entity-Specific Rating Rationales

04 Apr 2025

RPG Life Sciences Limited: Ratings reaffirmed

06 Mar 2024

RPG Life Sciences Limited: Long-term rating upgraded to [ICRA]A+(Stable) and short-term rating reaffirmed at [ICRA]A1

15 Dec 2022

RPG Life Sciences Limited: Ratings reaffirmed

Entity-Specific Credit Perspective Reports

30 Apr 2025

RPG Life Sciences Limited

RPG Life Sciences Limited (Non-SF)

03 Apr 2024

RPG Life Sciences Limited

RPG Life Sciences Limited (Non-SF)

Ratings

Description	Short Term	Medium Term	Long Term	Issuer
Term Loan	--	--	[ICRA]A+(Stable)	--
Fund Based Cash Credit	--	--	[ICRA]A+(Stable)	--
Short-term – Non Fund Based facilities	[ICRA]A1	--	--	--

Our Analysts

Analyst 1

Karan Gupta

91 22 6114 3421
karan.gupta@icraindia.com

Analyst 2

Sakshi Suneja

+91 22 61693345
sakshi.suneja@icraindia.com

Sector Head

Shamsher Dewan

124 4545 328
shamsherd@icraindia.com

Most Trending Research Reports

Rating Rationales

Upcoming Webinars

Presentations And Recordings

Coming Soon...

08 Apr 2025 04:00 PM

ICRA Webinar on the Indian Banking Sector - Regulatory easing to support credit growth in FY2026; asset quality remains monitorable

--By Mr Karthik Srinivasan,Mr Anil Gupta,Mr Sachin Sachdeva

PPT

Want To Listen

03 Apr 2025 04:00 PM

ICRA Webinar on Outlook FY2026

--By Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Karthik Srinivasan

PPT

Want To Listen

Podcast

ICRA Podcast on Banking Sector Outlook FY2026 | Insights by Sachin Sachdeva

Apr 2025

Media Release

Ask Our Industry Analyst

Get in touch with our Business Representative

You can show error msg here

(*Denotes Compulsory field)

Submit